Physician profile
Imari E Moore
NPI 1003182718
$2,016.34
in general payments reported to CMS, 2019-2025
19 companies · $18.15 in 2025
The $18.15 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $153 · 2021: $303 · 2022: $362 · 2023: $391 · 2024: $611 · 2025: $18.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.76 |
| Education | $183.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $389.35 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $344.93 | 2019-2024 | |
| Abbvie INC. | $265.81 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $230.60 | 2021-2024 | |
| Agile Therapeutics, INC. | $193.37 | 2021-2024 | Twirla |
| Hologic Sales and Service, LLC | $130.36 | 2019-2024 | Myosure Tissue Removal Device, Thinprep 2000 Processor, Aptima |
| Minerva Surgical, INC | $106.36 | 2023-2025 | |
| Therapeuticsmd, INC. | $77.07 | 2019-2022 | |
| Pfizer INC. | $66.86 | 2021-2022 | |
| Exeltis, USA INC. | $48.17 | 2020-2024 | Nuvessa |
| Organon LLC | $26.05 | 2024 | |
| Mission Pharmacal Company | $21.92 | 2020 | |
| Medicem INC. | $19.84 | 2020 | |
| Meditrina | $17.74 | 2023 | |
| Mylan Pharmaceuticals INC. | $16.82 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $16.64 | 2019 | |
| Alydia Health | $15.65 | 2021 | |
| Sage Therapeutics, LLC | $15.39 | 2024 | |
| Allergan, INC. | $13.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imari Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.